Alvotech announces exclusive partnership with Cipla for biosimiliars

Nov 4, 2020

Alvotech announced it has entered into an exclusive partnership with Cipla for two oncology biosimilars and three auto-immune biosimilars in South Africa. Under the agreement, Alvotech will be responsible for the development and supply of the products, while Cipla will be responsible for registration and commercialisation.

Print Page Mail Article